We sit down with Hazel & Ali Senz and Julia & Madeleine McGuire to explore the unique challenges and lessons that come when a parent faces cancer in this episode of Campfires of Hope’s “When Cancer Hits Home” series. Together, each mother-daughter duo reflects on what it was like to hear the diagnosis, how it reshaped family dynamics, and the different ways they each processed the experience at their stage of life. From parenting through uncertainty to growing closer through shared struggle, their honest conversation sheds light on both the hardships and the unexpected growth that cancer can bring.

In this episode of “When Cancer Hits Home”, our guests Kelsey Mora and Chris Balmaceda—mental health professionals who specialize in supporting both kids and adults in families impacted by cancer—share insights on the emotional and relational challenges families often face during a loved one’s cancer journey.

They offer practical communication strategies to help families process the experience, build trust, and create emotional safety. We also explore key signs that it may be time to seek outside support, and the therapeutic approaches Kelsey and Chris prioritize in their work. Finally, we take a closer look at where mental health care in the cancer space still needs to grow.

In the first episode of our “When Cancer Hits Home” series, Nancy Ferro and Mark Agnew share powerful stories of how cancer impacted their families and how those experiences ultimately led to the founding of two remarkable organizations: Epic Experience and Pickles Group.

Nancy and Mark reflect on how a cancer diagnosis reshaped their relationships, family dynamics, and life paths. We explore the origin stories, missions, and impact of their organizations, each created to support families navigating cancer. As they look back on their personal and organizational journeys, Nancy and Mark offer meaningful takeaways for families facing cancer today—and hope for what comes after.

Multiple myeloma survivor and patient advocate Valarie Traynham returns for part 2 to share her insights on what action can be taken to create change in clinical research inequities. Valarie dives into the critical need to raise awareness about disparities in access and representation. She offers actionable ideas for improving healthcare support, building trust, and empowering historically marginalized communities through education and inclusion.

We’re joined by Valarie Traynham, a multiple myeloma survivor and passionate patient advocate, for the first of a two-part episode in a conversation on equity in healthcare and clinical research. Valarie explores the historical and systemic roots of medical mistrust and how they continue to impact clinical trial participation among racially diverse communities and people with disabilities. She sheds light on the misconceptions that discourage participation and offers thoughtful solutions for building trust and improving access to clinical trials.

In Part 2 of our conversation with Dr. Breelyn Wilky and Dr. Christopher Lieu from the University of Colorado Cancer Center, we dive deeper into the patient experience and the innovation behind clinical trials. They share guidance on when to consider a trial during your cancer journey, what a “day in the life” looks like for trial participants, and how trials differ from standard treatments like chemotherapy or radiation.

We also explore the unique role of investigator-initiated trials—what they are, how they differ from pharmaceutical-sponsored studies, and why they’re essential for advancing personalized cancer care.

In the first of a two-part episode, we sit down with Dr. Breelyn Wilky and Dr. Christopher Lieu from the University of Colorado Cancer Center to explore the vital role of clinical trials in advancing cancer treatment. They break down common misconceptions around trial safety and effectiveness, and explain how participation can benefit both patients and the future of oncology. Whether you're considering a trial or just curious, their expert advice brings clarity and encouragement.

Edie Harrison returns to Campfires of Hope to share her unique journey with clinical trials. Diagnosed as NED since 2022, Edie didn't need a trial for treatment purposes. Instead, she researched and sought out a “circulating tumor DNA” clinical trial—a cutting-edge approach to monitoring and detecting the return of her original cancer. Listen to Edie’s story to discover how clinical trials are transforming cancer care beyond treatment.